학술논문

Venetoclax plus cytarabine and azacitidine in relapsed/refractory AML: An open-label, single-arm, phase 2 study
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, May 2024, 202)
Subject
Language
English
ISSN
18790852
09598049